Chen N, Li R, Wang E, Hu D, Tang Z
Department of Anesthesiology, Xiangya Hospital of Central South University, Changsha 410008, China.
Department of Anesthesiology, Hunan Provincial People's Hospital, Changsha 410005, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2022 Jul 20;42(7):1095-1099. doi: 10.12122/j.issn.1673-4254.2022.07.20.
To investigate the impact of postoperative serious cardiovascular adverse events (CAE) on outcomes of patients undergoing craniotomy for intracranial aneurysm clipping.
This retrospective cohort study was conducted among the patients undergoing craniotomy for intracranial aneurysm clipping during the period from December, 2016 to December, 2017, who were divided into CAE group and non-CAE group according to the occurrence of Clavien-Dindo grade ≥II CAEs after the surgery. The perioperative clinical characteristics of the patients, complications and neurological functions during hospitalization, and mortality and neurological functions at 1 year postoperatively were evaluated. The primary outcome was mortality within 1 year after the surgery. The secondary outcomes were Glasgow outcome scale (GOS) score at 1 year, lengths of postoperative hospital and intensive care unit (ICU) stay, and Glasgow coma scale (GCS) score at discharge.
A total of 361 patients were enrolled in the final analysis, including 20 (5.5%) patients in CAE group and 341 in the non-CAE group. No significant differences were found in the patients' demographic characteristics, clinical history, or other postoperative adverse events between the two groups. The 1-year mortality was significantly higher in CAE group than in the non-CAE group (20.0% 5.6%, =0.01). Logistics regression analysis showed that when adjusted for age, gender, emergency hospitalization, subarachnoid hemorrhage, volume of bleeding, duration of operation, aneurysm location, and preoperative history of cardiovascular disease, postoperative CAEs of Clavien-Dindo grade≥II was independently correlated with 1-year mortality rate of the patients with an adjusted odds ratio of 3.670 (95% : 1.037-12.992, =0.04). The patients with CEA also had a lower GOS score at 1 year after surgery than those without CEA (=0.002). No significant differences were found in the occurrence of other adverse events, postoperative hospital stay, ICU stay, or GCS scores at discharge between the two groups ( > 0.05).
Postoperative CAEs may be a risk factor for increased 1-year mortality and disability in patients undergoing craniotomy for intracranial aneurysms.
探讨术后严重心血管不良事件(CAE)对颅内动脉瘤夹闭开颅手术患者预后的影响。
本回顾性队列研究纳入了2016年12月至2017年12月期间接受颅内动脉瘤夹闭开颅手术的患者,根据术后是否发生Clavien-Dindo分级≥II级的CAE将患者分为CAE组和非CAE组。评估患者围手术期的临床特征、住院期间的并发症和神经功能,以及术后1年的死亡率和神经功能。主要结局是术后1年内的死亡率。次要结局包括术后1年的格拉斯哥预后量表(GOS)评分、术后住院时间和重症监护病房(ICU)住院时间,以及出院时的格拉斯哥昏迷量表(GCS)评分。
最终纳入361例患者进行分析,其中CAE组20例(5.5%),非CAE组341例。两组患者的人口统计学特征、临床病史或其他术后不良事件无显著差异。CAE组1年死亡率显著高于非CAE组(20.0%对5.6%,P=0.01)。Logistic回归分析显示,在调整年龄、性别、急诊住院、蛛网膜下腔出血、出血量、手术时间、动脉瘤位置和术前心血管疾病史后,Clavien-Dindo分级≥II级的术后CAE与患者1年死亡率独立相关,调整后的优势比为3.670(95%CI:1.037-12.992,P=0.04)。发生CAE的患者术后1年的GOS评分也低于未发生CAE的患者(P=0.002)。两组在其他不良事件的发生率、术后住院时间、ICU住院时间或出院时的GCS评分方面无显著差异(P>0.05)。
术后CAE可能是颅内动脉瘤开颅手术患者1年死亡率和致残率增加的危险因素。